Product Categories
| Country: | United States |
|---|---|
| Tel: | 781-+1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | info@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| L-Moses；L-45 | C21H24N6 | 2079885-05-3 | Details |
| L-690488 | C32H52O16P2 | 142523-14-6 | Details |
| L-692429；MK-0751 | C29H31N7O2 | 145455-23-8 | Details |
| L-745870 hydrochloride | C18H20Cl2N4 | 1173023-36-3 | Details |
| L-745870 | C18H19ClN4 | 158985-00-3 | Details |
| Blonanserin；AD-5423 | C23H30FN3 | 132810-10-7 | Details |
| L-803087 | C25H29F2N5O3 | 217480-26-7 | Details |
| l-Atabrine dihydrochloride | C23H31Cl2N3O | 56100-42-6 | Details |
| L-Canaline | C4H10N2O3 | 496-93-5 | Details |
| L-Cysteinesulfinic acid | C3H7NO4S | 1115-65-7 | Details |
| β3-AR agonist 2 | C27H38N4O7S | 340757-05-3 | Details |
| L-NIL | C8H17N3O2 | 53774-63-3 | Details |
| L-NIO dihydrochloride | C7H16ClN3O2 | 159190-44-0 | Details |
| L002 | C15H15NO5S | 321695-57-2 | Details |
| L162389 | C31H38N4O4S | 169281-53-2 | Details |
| L162441 | C34H43N5O5S | 154512-46-6 | Details |
| Gefitinib；ZD1839 | C22H24ClFN4O3 | 184475-35-2 | Details |
| L791943 | C24H17F10NO4 | 192767-01-4 | Details |
| Laetanine | C18H19NO4 | 72361-67-2 | Details |
| L-Eflornithine；L-DFMO;L-RMI71782;L-α-difluoromethylornithine | C6H12F2N2O2 | 66640-93-5 | Details |
| L-Eflornithine monohydrochloride；L-DFMO monohydrochloride;L-α-difluoromethylornithine monohydrochloride;L-RMI71782 monohydrochloride | C6H13ClF2N2O2 | 69955-42-6 | Details |
| Laflunimus；HR325 | C15H13F3N2O2 | 147076-36-6 | Details |
| Lamivudine 13C,15N2 | C8H9N3O4S | 1391052-30-4 | Details |
| Lanopepden；GSK 1322322 | C22H34FN7O4 | 1152107-25-9 | Details |
| Lansoprazole-d4；AG-1749 D4;Lansoprazole D4 | C16H10D4F3N3O2S | 934294-22-1 | Details |
| Lansoprazole Sulfide D4 | C16H14F3N3OS | 1216682-38-0 | Details |
| LAS191954 | C20H15N9O | 1403947-26-1 | Details |
| Lascufloxacin；KRP-AM1977X | C21H24F3N3O4 | 848416-07-9 | Details |
| Levocarnitine propionate hydrochloride；ST-261;Propionyl-L-carnitine hydrochloride;L-Propionylcarnitine chloride | C10H20ClNO4 | 119793-66-7 | Details |
| LAT1-IN-1；BCH | C8H13NO2 | 20448-79-7 | Details |
| Latanoprost lactone diol | C18H24O4 | 145667-75-0 | Details |
| LAU159 | C17H12ClN3O2 | 2055050-87-6 | Details |
| LB-60-OF61 | C29H30N6O2 | 794461-93-1 | Details |
| Lanraplenib succinate；GS-9876 succinate | C27H31N9O5 | 1800047-00-0 | Details |
| Lanraplenib monosuccinate；GS-9876 monosuccinate | C27H31N9O5 | 1800046-97-2 | Details |
| Lanraplenib；GS-9876 | C23H25N9O | 1800046-95-0 | Details |
| LCB-2853 | C21H24ClNO4S | 141335-10-6 | Details |
| LCH-7749944；GNF-PF-2356 | C20H22N4O2 | 796888-12-5 | Details |
| Pradigastat；LCQ-908 | C25H24F3N3O2 | 956136-95-1 | Details |
| LDH-IN-1 | C30H26N4O4S2 | 1964515-43-2 | Details |
| Retinol；all-trans-Retinol;Vitamin A1;Alphalin;Vitamin A | C20H30O | 68-26-8 | Details |
| LDN-192960 hydrochloride | C18H21ClN2O2S | 2309172-48-1 | Details |
| LDN-27219 | C20H16N4O2S2 | 312946-37-5 | Details |
| Ledipasvir D-tartrate；GS-5885 D-tartrate | C53H60F2N8O12 | 1502654-87-6 | Details |
| Ledipasvir (diacetone)；GS-5885 diacetone | C55H66F2N8O8 | 1502655-48-2 | Details |
| Leelamine hydrochloride | C20H32ClN | 16496-99-4 | Details |
| KD-3010 | C30H33F3N2O8S2 | 934760-92-6 | Details |
| KDM2A/7A-IN-1 | C33H38N4O | 2169272-46-0 | Details |
| KDM4-IN-2 | C25H26N6O | 2369607-62-3 | Details |
| Bromopride；Valopride;Artomey;Bromoprida | C14H22BrN3O2 | 4093-35-0 | Details |
| KDOAM-25 | C15H25N5O2 | 2230731-99-2 | Details |
| Keap1-Nrf2-IN-1；Keap1–Nrf2-IN-1 | C24H24N2O7S | 2232112-72-8 | Details |
| Keto Ziprasidone | C21H19ClN4O2S | 884305-07-1 | Details |
| Ketorolac-d5；Ketorolac D5 | C15H13NO3 | 1215767-66-0 | Details |
| KF 13218 | C20H20N2O3 | 127654-03-9 | Details |
| Kgp-IN-1 | C19H24F4N4O3 | 2097865-36-4 | Details |
| KHK-IN-2 | C16H19F3N4O3 | 2135304-43-5 | Details |
| KI696 isomer | C28H30N4O6S | 1799974-69-8 | Details |
| KI696 | C28H30N4O6S | 1799974-70-1 | Details |
| Kif15-IN-2 | C20H20N6O4S | 672926-33-9 | Details |
| Racecadotril；Acetorphan | C21H23NO4S | 81110-73-8 | Details |
| KIN101；3-(4-Bromophenyl)-7-[(methylsulfonyl)oxy]-4-oxo-4H-chromene | C16H11BrO5S | 610753-87-2 | Details |
| Tarlox-TKI；Kinase inhibitor-1 | C19H18BrClN6O | 2135696-72-7 | Details |
| Kira8 Hydrochloride；AMG-18 Hydrochloride | C31H30Cl2N6O3S | 2250019-92-0 | Details |
| Kira8；AMG-18 | C31H29ClN6O3S | 1630086-20-2 | Details |
| Ko-3290 | C19H25N3O3 | 79848-61-6 | Details |
| KP496 | C31H34ClN3O7S3 | 217799-03-6 | Details |
| KPLH1130 | C15H13N3O3 | 906669-07-6 | Details |
| Eltanexor Z-isomer；KPT-8602 (Z-isomer) | C17H10F6N6O | 1642300-78-4 | Details |
| Eltanexor；KPT-8602;ONO-7706;ATG-016 | C17H10F6N6O | 1642300-52-4 | Details |
| KRAS G12C inhibitor 13 | C40H46F3N7O4 | 2241719-75-3 | Details |
| KRAS inhibitor-6 | C27H30ClF2N5O3 | 2022986-61-2 | Details |
| KRAS inhibitor-7 | C26H27ClF2N6O2 | 2022986-68-9 | Details |
| KRAS G12C inhibitor 15 | C25H21ClF2N4O3 | 2349393-21-9 | Details |
| KRAS G12C inhibitor 16 | C24H21ClFN3O3 | 2349392-79-4 | Details |
| KRAS G12C inhibitor 17 | C24H20ClF2N3O3 | 2349393-04-8 | Details |
| KRAS inhibitor-4 | C30H39ClN8O | 2374152-69-7 | Details |
| KRAS inhibitor-8 | C26H24ClF4N5O3 | 2022986-70-3 | Details |
| KRas G12C inhibitor 1 | C31H38N6O3 | 2158297-28-8 | Details |
| KRas G12C inhibitor 2 | C32H37N7O3 | 2206735-61-5 | Details |
| KRas G12C inhibitor 3 | C32H36ClN7O2 | 2206735-75-1 | Details |
| KRas G12C inhibitor 4 | C33H38ClN7O2 | 2206736-07-2 | Details |
| Tiotropium bromide；BA679 BR;Tiopropium | C19H22BrNO4S2 | 136310-93-5 | Details |
| Kv3 modulator 4 | C20H24N2O4 | 2173375-10-3 | Details |
| KW-6055 | C16H17N3O3 | 63233-46-5 | Details |
| KW-8232 free base | C36H37ClN4O3 | 170365-25-0 | Details |
| KY-05009 | C18H16N4O2S | 1228280-29-2 | Details |
| L-368,899 hydrochloride | C26H42N4O5S2 | 160312-62-9 | Details |
| L-4-Oxalysine hydrochloride | C5H13ClN2O3 | 118021-35-5 | Details |
| Temozolomide；NSC 362856;TMZ;TZM;CCRG 81045 | C6H6N6O2 | 85622-93-1 | Details |
| KRAS G12C inhibitor 5 | C32H37N7O2 | 2158297-63-1 | Details |
| KRN2 | C27H23ClFNO4 | 248260-75-5 | Details |
| KRN2 bromide | C27H23BrFNO4 | 1390654-28-0 | Details |
| KSI-3716 | C17H11BrCl2N2O2 | 1151813-61-4 | Details |
| KT182 | C27H26N4O2 | 1402612-62-7 | Details |
| KT203 | C28H26N4O3 | 1402612-64-9 | Details |
| KUL-7211 racemate；KUL 7211 racemate | C19H23NO5 | 911196-40-2 | Details |
| Kv3 modulator 1 | C20H20N4O4 | 1380696-64-9 | Details |
| Kv3 modulator 2 | C21H21N3O4 | 2101321-76-8 | Details |
| Kv3 modulator 3 | C19H18N4O3 | 1498186-01-8 | Details |
| Product Total： Product Page： | ||||
| 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 | ||||